|
G |
Abcc5 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
multiple interactions |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [ABCC5 protein results in decreased susceptibility to Fluorouracil]; 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [ABCC5 protein results in decreased susceptibility to Thioguanine] |
CTD |
PMID:15897250 |
|
NCBI chr16:20,331,303...20,426,428
Ensembl chr16:20,331,303...20,426,394
|
|
G |
Ano6 |
anoctamin 6 |
decreases activity |
EXP |
5-nitro-2-(3-phenylpropylamino)benzoic acid results in decreased activity of ANO6 protein |
CTD |
PMID:24478309 |
|
NCBI chr15:95,790,843...95,975,472
Ensembl chr15:95,790,843...95,974,751
|
|
G |
Aqp3 |
aquaporin 3 |
multiple interactions |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid promotes the reaction [VIP protein results in increased expression of AQP3 mRNA] |
CTD |
PMID:12542607 |
|
NCBI chr 4:41,092,724...41,098,183
Ensembl chr 4:41,092,722...41,098,183
|
|
G |
Atf2 |
activating transcription factor 2 |
multiple interactions |
EXP |
5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [TNF protein promotes the reaction [MAPK1 protein results in increased phosphorylation of ATF2 protein]] |
CTD |
PMID:9918806 |
|
NCBI chr 2:73,816,509...73,892,677
Ensembl chr 2:73,816,509...73,892,639
|
|
G |
Best1 |
bestrophin 1 |
decreases activity |
EXP |
5-nitro-2-(3-phenylpropylamino)benzoic acid results in decreased activity of BEST1 protein |
CTD |
PMID:19828819 |
|
NCBI chr19:9,985,172...10,001,633
Ensembl chr19:9,985,174...10,001,633
|
|
G |
Casp3 |
caspase 3 |
decreases expression |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid results in decreased expression of CASP3 protein |
CTD |
PMID:21538933 |
|
NCBI chr 8:46,617,291...46,639,698
Ensembl chr 8:46,617,291...46,639,689
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid results in increased expression of CCND1 mRNA |
CTD |
PMID:21538933 |
|
NCBI chr 7:144,929,931...144,939,831
Ensembl chr 7:144,929,931...144,939,925
|
|
G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
multiple interactions decreases activity |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid analog binds to and results in increased activity of CFTR protein; 5-nitro-2-(3-phenylpropylamino)benzoic acid analog binds to and results in increased activity of CFTR protein mutant form; 5-nitro-2-(3-phenylpropylamino)benzoic acid binds to and results in increased activity of CFTR protein; 5-nitro-2-(3-phenylpropylamino)benzoic acid binds to and results in increased activity of CFTR protein mutant form 5-nitro-2-(3-phenylpropylamino)benzoic acid results in decreased activity of CFTR protein |
CTD |
PMID:15131065 PMID:15277574 PMID:15389550 PMID:15634668 PMID:15802612 PMID:15857825 |
|
NCBI chr 6:18,170,687...18,322,770
Ensembl chr 6:18,170,687...18,322,768
|
|
G |
Clcn3 |
chloride channel, voltage-sensitive 3 |
decreases activity increases expression multiple interactions |
EXP ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid results in decreased activity of CLCN3 protein 5-nitro-2-(3-phenylpropylamino)benzoic acid results in increased expression of CLCN3 mRNA [5-nitro-2-(3-phenylpropylamino)benzoic acid results in increased expression of CLCN3 mRNA] which results in decreased susceptibility to Cisplatin |
CTD |
PMID:17699636 PMID:21538933 |
|
NCBI chr 8:60,910,389...60,983,317
Ensembl chr 8:60,910,389...60,983,300
|
|
G |
Gpr35 |
G protein-coupled receptor 35 |
multiple interactions |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid binds to and results in increased activity of GPR35 protein |
CTD |
PMID:20826425 |
|
NCBI chr 1:92,948,052...92,986,391
Ensembl chr 1:92,950,865...92,986,391
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
EXP |
5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitrites]; 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA]; 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [IFNG protein results in increased metabolism of Nitric Oxide] |
CTD |
PMID:9918806 PMID:19446535 |
|
NCBI chr10:118,441,046...118,445,894
Ensembl chr10:118,441,046...118,445,892
|
|
G |
Jun |
jun proto-oncogene |
multiple interactions |
EXP |
5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [TNF protein results in increased phosphorylation of JUN protein] |
CTD |
PMID:9918806 |
|
NCBI chr 4:95,049,036...95,052,222
Ensembl chr 4:95,049,034...95,052,222
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions |
EXP |
5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [TNF protein promotes the reaction [MAPK1 protein results in increased phosphorylation of ATF2 protein]] |
CTD |
PMID:9918806 |
|
NCBI chr16:16,983,382...17,047,453
Ensembl chr16:16,983,382...17,047,453
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
multiple interactions |
EXP |
5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA] |
CTD |
PMID:19446535 |
|
NCBI chr11:78,920,787...78,960,226
Ensembl chr11:78,920,787...78,960,254
|
|
G |
Panx1 |
pannexin 1 |
decreases activity |
EXP |
5-nitro-2-(3-phenylpropylamino)benzoic acid results in decreased activity of PANX1 protein |
CTD |
PMID:19023039 |
|
NCBI chr 9:15,005,785...15,045,478
Ensembl chr 9:15,002,128...15,045,478
|
|
G |
Sct |
secretin |
decreases activity |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid results in decreased activity of SCT protein |
CTD |
PMID:10880878 |
|
NCBI chr 7:141,278,329...141,279,174
Ensembl chr 7:141,278,330...141,279,133
|
|
G |
Slc16a1 |
solute carrier family 16 (monocarboxylic acid transporters), member 1 |
multiple interactions |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] |
CTD |
PMID:19023563 |
|
NCBI chr 3:104,638,664...104,658,462
Ensembl chr 3:104,638,668...104,658,462
|
|
G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
multiple interactions |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine] |
CTD |
PMID:27979590 |
|
NCBI chr 8:70,882,885...70,892,785
Ensembl chr 8:70,882,889...70,892,757
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitrites]; 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [TNF protein promotes the reaction [MAPK1 protein results in increased phosphorylation of ATF2 protein]]; 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [TNF protein results in increased phosphorylation of JUN protein]; 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [TNF protein results in increased transport of Chlorides] |
CTD |
PMID:9918806 PMID:10783394 |
|
NCBI chr17:35,199,367...35,202,007
Ensembl chr17:35,199,381...35,202,007
|
|
G |
Vip |
vasoactive intestinal polypeptide |
multiple interactions |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid promotes the reaction [VIP protein results in increased expression of AQP3 mRNA] |
CTD |
PMID:12542607 |
|
NCBI chr10:5,639,193...5,647,617
Ensembl chr10:5,639,218...5,647,617
|
|
|
G |
Adora1 |
adenosine A1 receptor |
multiple interactions |
ISO |
[Dithiothreitol co-treated with Dithionitrobenzoic Acid] inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein]; Cadmium Chloride promotes the reaction [Dithionitrobenzoic Acid inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein]]; Dithionitrobenzoic Acid inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein]; Dithionitrobenzoic Acid promotes the reaction [Cadmium Chloride inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein]]; Dithiothreitol inhibits the reaction [Dithionitrobenzoic Acid inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein]] |
CTD |
PMID:10413299 |
|
NCBI chr 1:134,199,215...134,235,457
Ensembl chr 1:134,199,223...134,235,431
|
|
G |
Alb |
albumin |
multiple interactions increases reduction |
ISO |
[ALB protein binds to Docosahexaenoic Acids] inhibits the reaction [ALB protein results in increased reduction of Dithionitrobenzoic Acid]; [ALB protein binds to Eicosapentaenoic Acid] inhibits the reaction [ALB protein results in increased reduction of Dithionitrobenzoic Acid]; [ALB protein binds to Myristic Acid] promotes the reaction [ALB protein results in increased reduction of Dithionitrobenzoic Acid]; [ALB protein binds to Oleic Acid] promotes the reaction [ALB protein results in increased reduction of Dithionitrobenzoic Acid]; [ALB protein binds to Palmitic Acid] promotes the reaction [ALB protein results in increased reduction of Dithionitrobenzoic Acid]; [ALB protein binds to stearic acid] promotes the reaction [ALB protein results in increased reduction of Dithionitrobenzoic Acid]; [ALB protein modified form binds to Myristic Acid] which results in decreased reduction of Dithionitrobenzoic Acid; [ALB protein modified form binds to Oleic Acid] which results in decreased reduction of Dithionitrobenzoic Acid; [ALB protein modified form binds to Palmitic Acid] which results in decreased reduction of Dithionitrobenzoic Acid; [ALB protein modified form binds to stearic acid] which results in decreased reduction of Dithionitrobenzoic Acid; [Pyruvaldehyde results in increased oxidation of ALB protein] which results in decreased reduction of Dithionitrobenzoic Acid |
CTD |
PMID:25451573 |
|
NCBI chr 5:90,460,870...90,476,602
Ensembl chr 5:90,460,897...90,476,602
|
|
G |
Mt3 |
metallothionein 3 |
affects metabolic processing |
ISO |
MT3 protein polymorphism affects the metabolism of Dithionitrobenzoic Acid |
CTD |
PMID:14983064 |
|
NCBI chr 8:94,152,607...94,154,148
Ensembl chr 8:94,152,607...94,154,146
|
|
G |
Ptgr1 |
prostaglandin reductase 1 |
multiple interactions |
ISO |
Dithionitrobenzoic Acid inhibits the reaction [PTGR1 protein results in increased reduction of 10-nitro-oleic acid analog]; Dithionitrobenzoic Acid inhibits the reaction [PTGR1 protein results in increased reduction of 15-ketoprostaglandin E2] |
CTD |
PMID:23878198 |
|
NCBI chr 4:58,965,590...58,987,131
Ensembl chr 4:58,965,439...58,987,119
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
multiple interactions affects metabolic processing increases reduction |
EXP ISO |
Dinitrochlorobenzene inhibits the reaction [TXNRD1 protein affects the metabolism of Dithionitrobenzoic Acid]; diphenyleneiodonium inhibits the reaction [TXNRD1 protein affects the metabolism of Dithionitrobenzoic Acid]; Gold Sodium Thiomalate inhibits the reaction [TXNRD1 protein affects the metabolism of Dithionitrobenzoic Acid] TXNRD1 protein results in increased reduction of Dithionitrobenzoic Acid [Dinitrochlorobenzene binds to TXNRD1 protein] inhibits the reaction [TXNRD1 protein results in increased reduction of Dithionitrobenzoic Acid]; Dithionitrobenzoic Acid inhibits the reaction [[TXNRD1 protein co-treated with NADP] results in increased abundance of Superoxides]; Ferrous Compounds inhibits the reaction [TXNRD1 protein results in increased reduction of Dithionitrobenzoic Acid] |
CTD |
PMID:17229725 PMID:20457604 PMID:21172426 |
|
NCBI chr10:82,833,951...82,897,724
Ensembl chr10:82,833,951...82,897,712
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
increases reduction |
ISO |
TXNRD2 protein results in increased reduction of Dithionitrobenzoic Acid |
CTD |
PMID:21172426 |
|
NCBI chr16:18,426,417...18,479,073
Ensembl chr16:18,426,384...18,479,073
|
|
|
G |
Ahr |
aryl-hydrocarbon receptor |
multiple interactions |
EXP |
bifenox binds to and results in increased activity of AHR protein |
CTD |
PMID:18835618 |
|
NCBI chr12:35,497,979...35,534,989
Ensembl chr12:35,497,974...35,535,038
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
bifenox inhibits the reaction [Metribolone results in increased activity of AR protein]; Dihydrotestosterone inhibits the reaction [bifenox results in increased activity of AR protein] |
CTD |
PMID:15064155 PMID:18324785 |
|
NCBI chr X:98,148,757...98,323,218
Ensembl chr X:98,148,769...98,323,215
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
EXP ISO |
bifenox binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:21115097 |
|
NCBI chr16:38,248,349...38,294,849
Ensembl chr16:38,248,323...38,294,824
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases activity |
ISO |
bifenox results in increased activity of NR1I3 protein |
CTD |
PMID:28927721 |
|
NCBI chr 1:171,213,934...171,218,845
Ensembl chr 1:171,213,970...171,220,701
|
|